健友股份(603707)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

603707 健友股份

已收盘 12-19 15:00:00

{"stockData":{"symbol":"603707","market":"SH","secType":"STK","nameCN":"健友股份","latestPrice":13.45,"timestamp":1734591600000,"preClose":13.45,"halted":0,"volume":4288370,"delay":0,"floatShares":1616000000,"shares":1616000000,"eps":-0.2618,"marketStatus":"已收盘","marketStatusCode":5,"change":0,"latestTime":"12-19 15:00:00","open":13.34,"high":13.53,"low":13.25,"amount":57357900,"amplitude":0.0208,"askPrice":13.46,"askSize":250,"bidPrice":13.45,"bidSize":28,"shortable":0,"etf":0,"ttmEps":-0.2618,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734658200000},"adr":0,"adjPreClose":13.45,"symbolType":"stock","openAndCloseTimeList":[[1734571800000,1734579000000],[1734584400000,1734591600000]],"highLimit":14.8,"lowLimit":12.11,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1615634520,"pbRate":3.49,"roa":"--","roe":"10.08%","epsLYR":-0.12,"committee":-0.550706,"marketValue":21730000000,"floatMarketCap":21730000000,"peRate":-51.375097,"changeRate":0,"turnoverRate":0.0027,"status":2},"requestUrl":"/m/hq/s/603707/tweets","defaultTab":"tweets","newsList":[{"id":"2491301385","title":"健友股份12月13日遭主力抛售1353万元 环比增加544.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491301385","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491301385?lang=zh_cn&edition=full","pubTime":"2024-12-13 15:20","pubTimestamp":1734074435,"startTime":"0","endTime":"0","summary":"12月13日, 健友股份股价跌2.92%，报收13.97元，成交金额1.39亿元，换手率0.61%，振幅3.75%，量比1.53。健友股份今日主力资金净流出1353万元，连续5日净流出，上一交易日主力净流出210万元，今日环比增加544.29%。近一年数据显示，该股主力连续5日净流出后，次日下跌概率为66.67%，平均跌幅为1.71%。该股近5个交易日上涨0.36%，主力资金累计净流出2261万元；近20日主力资金累计净流出4114万元，其中净流出天数为16日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213154202a1eb52e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213154202a1eb52e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603707","BK0046","BK0186"],"gpt_icon":0},{"id":"2490887366","title":"健友股份12月11日遭主力抛售341万元 环比增加114.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490887366","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490887366?lang=zh_cn&edition=full","pubTime":"2024-12-11 15:19","pubTimestamp":1733901576,"startTime":"0","endTime":"0","summary":"12月11日, 健友股份股价涨2.06%，报收14.40元，成交金额1.16亿元，换手率0.50%，振幅4.25%，量比1.46。健友股份今日主力资金净流出341万元，连续3日净流出，上一交易日主力净流出159万元，今日环比增加114.47%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为47.37%，平均跌幅为1.31%。该股近5个交易日上涨5.80%，主力资金累计净流出18万元；近20日主力资金累计净流出2936万元，其中净流出天数为16日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211153259ab6edf6b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211153259ab6edf6b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0186","BK0239","603707","BK0046"],"gpt_icon":0},{"id":"2490188738","title":"研报掘金丨开源证券：首予健友股份“买入”评级，生物类似药迎来收获期","url":"https://stock-news.laohu8.com/highlight/detail?id=2490188738","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490188738?lang=zh_cn&edition=full","pubTime":"2024-12-11 14:57","pubTimestamp":1733900222,"startTime":"0","endTime":"0","summary":"开源证券研报指出，健友股份业务覆盖肝素原料药、肝素制剂、无菌注射剂、CDMO和生物药，近些年大力推进生物创新药和高端仿制产品的布局与拓展。随着公司布局的生物类似药逐步获批，有望带来较大业绩弹性。考虑公司在美国注射剂市场渠道的逐步拓展和生物类似药的布局，预计2024-2026年归母净利润为8.59/11.77/16.79亿元，当前股价对应PE分别为26.6/19.4/13.6倍，首次覆盖，给予“买入”评级。请读者仅作参考，并请自行承担全部责任。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211150125ab6eccfb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211150125ab6eccfb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["161027","603707"],"gpt_icon":0},{"id":"2490052562","title":"开源证券：给予健友股份买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2490052562","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490052562?lang=zh_cn&edition=full","pubTime":"2024-12-10 13:55","pubTimestamp":1733810118,"startTime":"0","endTime":"0","summary":"开源证券股份有限公司余汝意,阮帅近期对健友股份进行研究并发布了研究报告《公司首次覆盖报告：国际注射剂平台公司，生物类似药迎来收获期》，本报告对健友股份给出买入评级，当前股价为14.14元。最新盈利预测明细如下：该股最近90天内共有10家机构给出评级，买入评级6家，增持评级4家；过去90天内机构目标均价为18.52。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121000023006.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603707","161027"],"gpt_icon":0},{"id":"2488630961","title":"健友股份12月03日遭主力抛售836万元 环比增加273.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488630961","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488630961?lang=zh_cn&edition=full","pubTime":"2024-12-03 15:20","pubTimestamp":1733210413,"startTime":"0","endTime":"0","summary":"12月03日, 健友股份股价跌1.41%，报收14.00元，成交金额9097万元，换手率0.40%，振幅2.25%，量比1.14。健友股份今日主力资金净流出836万元，上一交易日主力净流出224万元，今日环比增加273.21%。该股近5个交易日上涨0.94%，主力资金累计净流出1561万元；近20日主力资金累计净流出3699万元，其中净流出天数为16日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203153414a268a5db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203153414a268a5db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0046","603707","BK0186","BK0239"],"gpt_icon":0},{"id":"2486387128","title":"1-10月医保统筹收入稳增长，机构：医药后市反转源于三大机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2486387128","media":"汇添富基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486387128?lang=zh_cn&edition=full","pubTime":"2024-11-28 08:11","pubTimestamp":1732752682,"startTime":"0","endTime":"0","summary":"消息面上，据医保局日前披露，2024年1-10月医保统筹基金收入23065.07亿元，同比增长8.9%；2024年1-10月统筹支出19165.88亿元，同比增长8.9%。对此，国泰君安表示，1-10月医保统筹基金运行平稳，收入稳健增长，支出增速逐月收窄。国金证券表示，由于多方面因素，医药板块景气度在2021年后经历了长时间的下行。2024年11月7日，国家医保局召开了座谈会，强调了全国统一医保平台和大数据赋能商保发展的重要性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112807590598e4504f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112807590598e4504f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600721","603108","BK0185","688163","603087","600976","600351","603858","600436","603939","688575","600380","600998","688331","603309","688266","600200","688278","600055","605199","603392","600161","600521","BK0070","600572","688192","688276","603439","600771","688506","688315","603567","600511","BK0096","688298","688356","600329","688193","600332","688581","688180","688336","600851","688076","688139","688198","600196","603127","600085","600129","688656","600080","603301","603658","600566","688373","688189","688067","605177","BK0012","600867","688221","688050","688488","688578","688687","688212","688105","688301","688670","600056","688046","688382","688091","688389","603456","688062","688085","603707","688566","600739","688235","688247","688428","600079","600062","688520","600763","603882","BK0239","688177","159938","603259","600252","603538","603896","688029","600420","688117","688658","688073","688351","BK0188","688222","688137","601607","688202","603590","600422","600535","688626","BK0028","688114","688176","600529","688690","600276","688443","600211","600285","688617","688767","688271","688321","688166","603367","603233","688161","600488"],"gpt_icon":0},{"id":"2486806278","title":"《新股》九源基因(02566.HK)公开发售超购近675倍  一手中签率20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486806278","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486806278?lang=zh_cn&edition=full","pubTime":"2024-11-28 03:20","pubTimestamp":1732735200,"startTime":"0","endTime":"0","summary":"九源基因公布招股结果，公开发售接获675.83倍认购，一手中签率20.01%，认购4,000股获稳派一手。按回拨机制，公开发售股份已增至2,269.94万股，占发售总数50%。股份预期周四挂牌。中国生物制药公司九源基因是次全球发售4,539.88万股，香港发售原占10%；招股价介乎11.48-12.56元。七名基石投资者包括︰和达香港、复星医药旗下复星实业、健友股份旗下香港健友、阿里健康旗下阿里健康香港、九州通旗下Jointown International、君亭酒店创办人吴启元及Delta Capital HK，合共认购3.5亿元公司股份。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20241126155516619_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20241126155516619_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1400052/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1571","BK1247","BK0239","BK0028","BK0201","BK0097","BK0039","BK1610","BK0250","BK1589","BK0187","BK0196","600998","BK0146","BK0012","BK0246","BK1591","301073","BK1593","BK0186","BK0046","BK1515","00241","BK0183","BK1142","603707","BK1191","BK1501","BK0077","BK0188","BK1189","02196","BK1584","BK1502"],"gpt_icon":1},{"id":"2486194108","title":"健友股份11月27日遭主力抛售134万元 环比增加570.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486194108","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486194108?lang=zh_cn&edition=full","pubTime":"2024-11-27 15:22","pubTimestamp":1732692138,"startTime":"0","endTime":"0","summary":"11月27日, 健友股份股价涨3.60%，报收14.37元，成交金额7309万元，换手率0.32%，振幅4.40%，量比1.08。健友股份今日主力资金净流出134万元，连续3日净流出，上一交易日主力净流出20万元，今日环比增加570.00%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为42.11%，平均跌幅为1.38%。该股近5个交易日下跌1.30%，主力资金累计净流入97万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流入540万元，其中净流入天数为6日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127154107abe29e69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127154107abe29e69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603707","BK0046","BK0239","BK0186"],"gpt_icon":0},{"id":"2484554161","title":"九源基因招股，引入复星、阿里健康、健友股份、九州通等7名基石投资者，11月28日香港上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2484554161","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484554161?lang=zh_cn&edition=full","pubTime":"2024-11-20 13:22","pubTimestamp":1732080120,"startTime":"0","endTime":"0","summary":"　　来自浙江杭州的生物制药公司九源基因，于今日起至下周一招股，预计2024年11月28日在港交所挂牌上市，华泰国际独家保荐。　　九源基因，计划全球发售4539.88万股H股，其中90%为国际发售、10%为公开发售，另有15%超额配股权，每股发售价介乎11.48港元至12.56港元，每手200股，最多募资约5.70亿港元。8款已上市产品包括骨科、肿瘤、血液领域的1款创新药械组合，2款生物制品、5款化学药品。九源基因已建立覆盖全国的销售及分销网络。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/2024-11-20/doc-incwsueq5437050.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1501","BK0188","BK0250","BK0196","BK1571","BK1189","BK1610","00241","BK0028","BK1591","BK0239","BK0012","BK1515","BK0077","600998","BK0183","BK0187","BK1247","BK1142","BK1584","BK0097","BK0046","BK0146","BK1589","BK0039","BK0186","02566","603707","BK0201","BK1502"],"gpt_icon":0},{"id":"2484710993","title":"健友股份11月19日主力资金流出47万元 连续7日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2484710993","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484710993?lang=zh_cn&edition=full","pubTime":"2024-11-19 15:21","pubTimestamp":1732000876,"startTime":"0","endTime":"0","summary":"11月19日, 健友股份股价涨0.56%，报收14.45元，成交金额5309万元，换手率0.23%，振幅3.13%，量比0.61。健友股份今日主力资金净流出47万元，连续7日净流出，上一交易日主力净流出695万元，今日环比减少93.24%。该股近5个交易日下跌7.07%，主力资金累计净流出1371万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出4531万元，其中净流出天数为14日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119153752a2450c3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119153752a2450c3b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0046","603707","BK0186","BK0239"],"gpt_icon":0},{"id":"2484764941","title":"健友股份获FDA批准维生素B12注射液，预计业绩向好","url":"https://stock-news.laohu8.com/highlight/detail?id=2484764941","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484764941?lang=zh_cn&edition=full","pubTime":"2024-11-18 17:35","pubTimestamp":1731922500,"startTime":"0","endTime":"0","summary":"财中社11月18日电健友股份 发布关于维生素B12注射液获得美国FDA药品注册批件的公告。该药品适用于因吸收不良导致的维生素B12缺乏症。根据公告，维生素B12注射液的原研药品由AMERICAN REGENT INC持有，并于1982年01月01日前获得FDA批准上市。美国市场上目前有37家企业的同规格维生素B12注射液获批，2023年该药品在美国市场的销售额约为1.2亿美元。新批准的产品将近期安排在美国上市销售，预计将对公司经营业绩产生积极影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118174143abcc26b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118174143abcc26b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0186","603707","BK0239","BK0046"],"gpt_icon":0},{"id":"2484646468","title":"健友股份(603707.SH)：维生素B12注射液获得美国FDA药品注册批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2484646468","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484646468?lang=zh_cn&edition=full","pubTime":"2024-11-18 17:30","pubTimestamp":1731922235,"startTime":"0","endTime":"0","summary":"健友股份(603707.SH)发布公告，公司于近日收到美国食品药品监督管理局(简称...","market":"sg","thumbnail":"https://img.zhitongcaijing.com/astock/9.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/9.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1212296.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0046","603707","BK0239","BK0186"],"gpt_icon":0},{"id":"2484339649","title":"健友股份最新公告：维生素B12注射液获得美国FDA药品注册批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2484339649","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484339649?lang=zh_cn&edition=full","pubTime":"2024-11-18 17:29","pubTimestamp":1731922198,"startTime":"0","endTime":"0","summary":"健友股份公告，公司于近日收到美国食品药品监督管理局（FDA）签发的维生素B12注射液的批准信。该药品适用于因吸收不良导致的维生素B12缺乏症。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111800024050.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","603707","BK0186","BK0239"],"gpt_icon":0},{"id":"2483179073","title":"健友股份11月15日主力资金流出26万元 连续5日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2483179073","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483179073?lang=zh_cn&edition=full","pubTime":"2024-11-15 15:20","pubTimestamp":1731655244,"startTime":"0","endTime":"0","summary":"11月15日, 健友股份股价跌0.61%，报收14.73元，成交金额7042万元，换手率0.29%，振幅1.48%，量比0.65。健友股份今日主力资金净流出26万元，连续5日净流出，上一交易日主力净流出360万元，今日环比减少92.78%。近一年数据显示，该股主力连续5日净流出后，次日下跌概率为62.50%，平均跌幅为1.91%。该股近5个交易日下跌4.54%，主力资金累计净流出1641万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出2834万元，其中净流出天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115153612abc3b11d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115153612abc3b11d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603707","BK0046","BK0239","BK0186"],"gpt_icon":0},{"id":"2483026093","title":"健友股份11月13日主力资金流出246万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2483026093","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483026093?lang=zh_cn&edition=full","pubTime":"2024-11-13 15:22","pubTimestamp":1731482554,"startTime":"0","endTime":"0","summary":"11月13日, 健友股份股价跌3.99%，报收14.93元，成交金额1.14亿元，换手率0.47%，振幅4.69%，量比0.95。健友股份今日主力资金净流出246万元，连续3日净流出，上一交易日主力净流出946万元，今日环比减少74.00%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为38.89%，平均跌幅为1.23%。该股近5个交易日下跌0.27%，主力资金累计净流出409万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出2810万元，其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113154215a232f538&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113154215a232f538&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0046","BK0186","BK0239","603707"],"gpt_icon":0},{"id":"2482726709","title":"健友股份11月12日遭主力抛售946万元 环比增加1355.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482726709","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482726709?lang=zh_cn&edition=full","pubTime":"2024-11-12 15:20","pubTimestamp":1731396044,"startTime":"0","endTime":"0","summary":"11月12日, 健友股份股价涨1.30%，报收15.55元，成交金额1.21亿元，换手率0.48%，振幅3.39%，量比0.91。健友股份今日主力资金净流出946万元，上一交易日主力净流出65万元，今日环比增加1355.38%。该股近5个交易日上涨4.01%，主力资金累计净流出223万元；近20日主力资金累计净流出2605万元，其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112153908a22f7d09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112153908a22f7d09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603707","BK0186","BK0239","BK0046"],"gpt_icon":0},{"id":"2482271070","title":"健友股份：生物类似药乘风启航 公司进入3.0发展阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2482271070","media":"招商证券","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482271070?lang=zh_cn&edition=full","pubTime":"2024-11-11 00:00","pubTimestamp":1731254400,"startTime":"0","endTime":"0","summary":"24Q3 财务费用5670 万元，环比增加4613 万元，主要系Q3美元汇率波动所致。公司生物类似药管线已有8 个产品布局，进入生物药/大分子驱动的3.0 发展阶段。公司生物类似药产品覆盖糖尿病、肿瘤、生殖和自身免疫领域，商业化产品1 个，在研产品7 个。生物类似药迎来黄金发展时期，公司有望乘风启航。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111116312195be0db1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111116312195be0db1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0046","603707","BK0239","BK0186"],"gpt_icon":0},{"id":"2481976136","title":"健友股份：三季度业绩恢复延续 海外生物制剂步入兑现期","url":"https://stock-news.laohu8.com/highlight/detail?id=2481976136","media":"湘财证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481976136?lang=zh_cn&edition=full","pubTime":"2024-11-07 00:00","pubTimestamp":1730908800,"startTime":"0","endTime":"0","summary":"Q3 收入延续增长态势，利润下滑幅度收窄受到原料药周期波动及国内制剂集采等多重因素影响，公司收入增速自2023Q3 出现波动，经过三个季度逐步出清，2024Q2 恢复增长，Q3 延续增长态势，收入增速实现12.79%，连续两个季度实现正增长。利润端同步呈现恢复趋势，Q3 下滑幅度收窄至个位数。公司毛利率呈现稳步回升态势，2024Q3 毛利率44.1%，环比上升2.3pp。同时肝素原料药业务风险已经释放，当前原料药价格及出口量均处于历史低位区间，呈现温和复苏态势。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110718261995bde4cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110718261995bde4cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0046","BK0186","603707","BK0239"],"gpt_icon":0},{"id":"2480593305","title":"健友股份达肝素钠注射液通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2480593305","media":"北京商报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480593305?lang=zh_cn&edition=full","pubTime":"2024-11-04 19:01","pubTimestamp":1730718060,"startTime":"0","endTime":"0","summary":"北京商报讯（记者 丁宁）11月4日晚间，健友股份（603707）发布公告称，公司于近日收到国家药品监督管理局签发的达肝素钠注射液0.3ml：7500AⅩaIU规格的药品补充申请批准证书，批准本品通过仿制药质量和疗效一致性评价。健友股份表示，根据国家相关政策规定，通过一致性评价的药品品种在医保支付及医疗机构采购等领域将获得更大的支持力度，公司达肝素钠注射液通过一致性评价，有利于扩大该产品的市场销售，提高市场竞争力。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2024-11-04/doc-incuxccz2027929.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-11-04/doc-incuxccz2027929.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["603707","BK0186","BK0239","BK0046"],"gpt_icon":0},{"id":"2480372637","title":"健友股份(603707.SH)：达肝素钠注射液通过仿制药质量和疗效一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2480372637","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480372637?lang=zh_cn&edition=full","pubTime":"2024-11-04 17:53","pubTimestamp":1730714004,"startTime":"0","endTime":"0","summary":"智通财经APP讯，健友股份(603707.SH)发布公告，公司于近日收到国家药品监督管理局签发的达肝素钠注射液0.3ml：7500AⅩaIU规格的药品补充申请批准证书(药品批准文号为国药准字H20201000，通知书编号为2024B05042)，批准本品通过仿制药质量和疗效一致性评价。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1206359.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0239","603707","BK0046","BK0186"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2017-07-19","address":"江苏省南京市浦口区高新开发区MA010-1号地","stockEarnings":[{"period":"1week","weight":-0.066},{"period":"1month","weight":-0.064},{"period":"3month","weight":0.0451},{"period":"6month","weight":0.1128},{"period":"1year","weight":-0.1316},{"period":"ytd","weight":-0.0957}],"companyName":"南京健友生化制药股份有限公司","boardCode":"AI0027","perCapita":"95054股","boardName":"医药制造业","registeredCapital":"161563万元","compareEarnings":[{"period":"1week","weight":-0.0146},{"period":"1month","weight":0.0176},{"period":"3month","weight":0.2362},{"period":"6month","weight":0.1281},{"period":"1year","weight":0.1534},{"period":"ytd","weight":0.1369}],"survey":"　　南京健友生化制药股份有限公司主营业务是药品原料、制剂的研发、生产和销售。公司的主要产品包括肝素钠注射液、依诺肝素钠注射液、达肝素钠注射液等。公司秉承“建设世界一流的生物制药企业”的愿景，在“立足中美，放眼全球”的战略框架下，以注射剂为核心剂型，持续推进经营业务发展。通过对全球制剂业务的不断探索，公司在注射剂方向上广泛布局、积累了丰富的产品管线，主要包括低分子肝素制剂、抗肿瘤制剂及其他高附加值无菌注射剂，截至报告期末，公司及子公司共拥有97项境外药品注册批件，28项中国药品注册批件。","serverTime":1734606629339,"listedPrice":7.21,"stockholders":"16997人(较上一季度减少4.16%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"健友股份(603707)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供健友股份(603707)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"健友股份,603707,健友股份股票,健友股份股票老虎,健友股份股票老虎国际,健友股份行情,健友股份股票行情,健友股份股价,健友股份股市,健友股份股票价格,健友股份股票交易,健友股份股票购买,健友股份股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"健友股份(603707)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供健友股份(603707)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}